111 HUNTINGTON AVENUE,
BOSTON , MA, 02199

Rank

Rank Universe

Summary

The fund seeks capital appreciation by investing in companies across any size outside the United States.

The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.

Next, the research team invests in equity securities which include common stocks, equity interests in real estate investment t More

Link

Directors

Nov 13, 2023
  • Laurie J. Thomsen
  • Peter D. Jones
  • John P. Kavanaugh
  • Michael W. Roberge
  • Maryanne L. Roepke
  • Clarence Otis, Jr.
  • Maureen R. Goldfarb
  • James W. Kilman, Jr.
  • Steven E. Buller
  • John A. Caroselli

Chief Compliance Officer

  • Rosa E. Licea-Mailloux

Fund Manager(s)

Price

  • $ 17.97 ( -0.03 )
    Dec 11, 2024
    Last Close
  • Net Assets
  • $243.9M
    Apr 24, 2024
  • Holding
  • 7
    Jul 25, 2024
    More

  • 52-Week High/Low
  • $18.28 - $15.25
  • Turnover
  • 41%
  • Expense Ratio
  • 1.77%

Company Name

Holding

Johnson & Johnson 2.08 %
Vertex Pharmaceuticals Inc 1.28 %
Accenture PLC 0.96 %
Mondelez International Inc 0.72 %
Amano Corp 0.63 %
Sankyu Inc 0.63 %
Sankyo Co Ltd 0.34 %
More 0.34 %

Documents

Prospectus

Annual Reports

Performance

YTD

-

3 Year

12.95%

5 Year

25.75%

Best

17.27%

2017

Worst

-11.69%

2022

Alpha

MVGBX S&P 500

Chart +